Nanoparticles for direct nose-to-brain delivery of drugs

International Journal of Pharmaceutics

Volumn 379, Issue 1-2, 2009, Pages 146-157

  Mistry, Alpesh ^a   Stolnik, Snjezana ^a   Illum, Lisbeth ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Chitosan; Drug delivery; Lectin; Nanoparticles; Olfactory; PEG; Toxicity; Trigeminal

Indexed keywords

BETA CYCLODEXTRIN; CARBON 13; CHITOSAN; CHOLERA TOXIN B SUBUNIT; CORTICOTROPIN[4-10]; COUMARIN; ESTRADIOL; GOLD; HYDROXOCOBALAMIN; INSULIN; IRIDIUM 192; IRON OXIDE; LECTIN; MACROGOL; MALTODEXTRIN; MANGANESE OXIDE; MELATONIN; MORPHINE; NANOPARTICLE; NERVE GROWTH FACTOR; NIMODIPINE; PLACEBO; POLYLACTIC ACID; POLYSTYRENE; RISPERIDONE; TITANIUM DIOXIDE; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN; WHEAT GERM AGGLUTININ;

ABSORPTION SPECTROSCOPY; ALZHEIMER DISEASE; AREA UNDER THE CURVE; CENTRAL NERVOUS SYSTEM; CHEMICAL MODIFICATION; DISEASE MODEL; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG RESEARCH; DRUG TRANSPORT; HUMAN; NANOTECHNOLOGY; NONHUMAN; OLFACTORY EPITHELIUM; OLFACTORY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; TRIGEMINAL NERVE; ZETA POTENTIAL;

ADMINISTRATION, INTRANASAL; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS;

EID: 68649090916     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.06.019     Document Type: Review

References (96)

1. Adams G.L., Boies L.R., and Hilger P.A. Boies's Fundamentals of Otolaryngology a Textbook of Ear, Nose and Throat Diseases (1989), Saunders, Philadelphia pp. 177-195
2. Almeida A.J., Alpar H.O., and Brown M.R.W. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(l-lactic acid) microspheres in rats, rabbits and guinea pigs. J. Pharm. Pharmacol. 45 (1993) 198-203
3. Baier P.C., Weinhold S.L., Huth V., Gottwald B., Ferstl R., and Hinze-Selch D. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal orexin a (hypocretin-1). Brain 131 (2008) 2734-2741
4. Behrens I., Vila Pena A.I., Alonso M.J., and Kissel T. Comparative uptake studies of bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm. Res. 19 (2002) 1185-1193
5. Benedict C., Kern W., Schultes B., Born J., and Hallschmid M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J. Clin. Endocrinol. Metab. 93 (2008) 1339-1344
6. Betbeder D., Sperandio S., Latapie J.P., de Nadai J., Etienne A., Zajac J.M., and Frances B. Biovector (tm) nanoparticles improve antinociceptive efficacy of nasal morphine. Pharm. Res. 17 (2000) 743-748
7. Bodian D., and Howe H.A. The rate of progression of poliomyelitis virus in nerves. Bull. Johns Hopkins Hosp. 69 (1941) 79-85
8. Born J., Lange T., Kern W., McGregor G.P., Bickel U., and Fehm H.L. Sniffing neuropeptide: a transnasal approach to the human brain. Nat. Neurosci. 5 (2002) 514-516
9. Brand G. Olfactory/trigeminal interactions in nasal chemoreception. Neurosci. Biobehav. Rev. 30 (2006) 908-917
10. Brodbelt A., and Stoodley M. CSF pathways: a review. Br. J. Neurosurg. 21 (2007) 510-520
11. Brooking J., Davis S.S., and Illum L. Transport of nanoparticles across the rat nasal mucosa. J. Drug Target. 9 (2001) 267-279
12. Burd G.D. Development of the olfactory nerve in the African clawed frog, Xenopus laevis. 1. Normal development. J. Comp. Neurol. 304 (1991) 123-134
13. Charlton S., Jones N.S., Davis S.S., and Illum L. Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device. Eur. J. Pharm. Sci. 30 (2007) 295-302
14. Charlton S., Davis S.S., and Illum L. Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system. J. Drug Target. 15 (2007) 370-377
15. Chen F., Zhang Z.-R., Yuan F., Qin X., Wang M., and Huang Y. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery. Int. J. Pharm. 349 (2008) 226-233
16. Chou K.-J., and Donovan M.D. Distribution of antihistamines into the CSF following intranasal delivery. Biopharm. Drug Dispos. 18 (1997) 335-346
17. Conner S.D., and Schmid S.L. Regulated portals of entry into the cell. Nature 422 (2003) 37-44
18. Costantino H.R., Illum L., Brandt G., Johnson P., and Quay S.C. Intranasal delivery: physiochemical and therapeutic aspects. Int. J. Pharm. 337 (2007) 1-24
19. Dahlin M., Jansson B., and Bjork E. Levels of dopamine in blood and brain following nasal administration to rats. Eur. J. Pharm. Sci. 14 (2001) 75-80
20. Dalpiaz A., Gavini E., Colombo G., Russo P., Bortolotti F., Ferraro L., Tanganelli S., Scatturin A., Menegatti E., and Giunchedi P. Brain uptake of an anti-ischemic agent by nasal administration of microparticles. J. Pharm. Sci. 97 (2008) 4889-4903
21. De Lorenzo A. Electron microscopy of the olfactory and gustatory pathways. Ann. Otol. Rhinol. Laryngol. 68 (1960) 410-420
22. De Lorenzo A. Taste and Smell in Vertebrates (1970), J&A Churchill, London pp. 151-176
23. Derad I., Willeke K., Pietrowsky R., Born J., and Fehm H.L. Intranasal angiotensin iI directly influences central nervous regulation of blood pressure. Am. J. hypertens. 11 (1998) 971-977
24. Des Rieux A., Ragnarsson E.G.E., Gullberg E., Preat V., Schneider Y.-J., and Artursson P. Transport of nanoparticles across an in vitro model of the human follicle associated epithelium. Eur. J. Pharm. Sci. 25 (2005) 455-465
25. Dhuria S., Hanson L., and Frey W.I. Intranasal drug targeting of hypocretin-1 (orexin-a) to the central nervous system. J. Pharm. Sci. (2008) (Published Online)
26. Edeling M.A., Smith C., and Owen D. Life of a clathrin coat: insights from clathrin and AP structures. Nat. Rev. Mol. Cell. Biol. 7 (2006) 32-44
27. Elder A., Gelein R., Silva V., Feikert T., Opanashuk L., Carter J., Potter R., Maynard A., Finkelstein J., and Oberdorster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 114 (2006) 1172-1178
28. Fu T., Burbage C., Tagge E.P., Brothers T., Willingham M.C., and Frankel A.E. Ricin toxin contains three lectin sites which contribute to its in vivo toxicity. Int. J. Immunopharmacol. 18 (1996) 685-692
29. Gao X., Wu B., Zhang Q., Chen J., Zhu J., Zhang W., Rong Z., Chen H., and Jiang X. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. J. Control. Release 121 (2007) 156-167
30. Gao X., Chen J., Tao W., Zhu J., Zhang Q., Chen H., and Jiang X. Uea I-bearing nanoparticles for brain delivery following intranasal administration. Int. J. Pharm. 340 (2007) 207-215
31. Gao X.L., Tao W.X., Lu W., Zhang Q.Z., Zhang Y., Jiang X.G., and Fu S.K. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials 27 (2006) 3482-3490
32. Gartner L.P., and Hiatt J.L. Color Atlas of Histology (2000), Lippincott Williams & Wilkins, Philadelphia
33. Goppert T.M., and Muller R.H. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J. Drug Target. 13 (2005) 179-187
34. Gumbiner B. Structure, biochemistry, and assembly of epithelial tight junctions. Am. J. Physiol. 253 (1987) C749-C758
35. Harush-Frenkel O., Rozentur E., Benita S., and Altschuler Y. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 9 (2008) 435-443
36. Huang Y., and Donovan M.D. Microsphere transport pathways in the rabbit nasal mucosa. Int. J. Pharm. Adv. 1 (1996) 298-309
37. Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur. J. Pharm. Sci. 11 (2000) 1-18
38. Illum L. Is nose-to-brain transport of drugs in man a reality?. J. Pharm. Pharmacol. 56 (2004) 3-17
39. Illum L. Nanoparticle systems for nasal delivery of drugs: a real improvement over simple systems?. J. Pharm. Sci. 96 (2006) 473-483
40. Ishikawa H., and Isayama Y. Evidence for sialyl glycoconjugates as receptors for Bordetella bronchiseptica on swine nasal mucosa. Infect. Immun. 55 (1987) 1607-1609
41. Jogani V.V., Shah P.J., Mishra P., Mishra A.K., and Misra A.R. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting. Alzheimer Dis. Assoc. Disord. 22 (2008) 116-124
42. Jones A.T. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides. Int. J. Pharm. 354 (2008) 34-38
43. Kaliner M., Marom Z., Patow C., and Shelhamer J. Human respiratory mucus. J. Allergy Clin. Immunol. 73 (1984) 318-323
44. Kern W., Born J., Schreiber H., and Fehm H.L. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 48 (1999) 557-563
45. Kumar M., Misra A., Babbar A.K., Mishra A.K., Mishra P., and Pathak K. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int. J. Pharm. 358 (2008) 285-291
46. Kumar M., Misra A., Mishra A.K., Mishra P., and Pathak K. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. J. Drug Target. 16 (2008) 806-814
47. Lai S.K., O'Hanlon D.E., Harrold S., Man S.T., Wang Y.Y., Cone R., and Hanes J. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 1482-1487
48. Lenaerts V., and Gurny R. Bioadhesive Drug Delivery Systems (1990), CRC Press, Boca Raton, USA pp. 12-13
49. Lledo P.M., Gheusi G., and Vincent J.D. Information processing in the mammalian olfactory system. Physiol. Rev. 85 (2005) 281-317
50. Ma Z., and Lim L.-Y. Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles. Pharm. Res. 20 (2003) 1812-1819
51. Matsuzaki O. Numbers of olfactory receptor-cells and pine structure of olfactory nerves in various birds. Zool. Sci. 12 (1995) 117-123
52. Mayor S., and Pagano R.E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell. Biol. 8 (2007) 603-612
53. McMartin C., Hutchinson L.E.F., Hyde R., and Peters G.E. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J. Pharm. Sci. 76 (1987) 535-540
54. Menache M.G., Hanna L.M., Gross E.A., Lou S.R., Zinreich S.J., Leopold D.A., Jarabek A.M., and Miller F.J. Upper respiratory tract surface areas and volumes of laboratory animals and humans: considerations for dosimetry models. J. Toxicol. Environ. Health 50 (1997) 475-506
55. Merkus F.W.H.M., and van den Berg M.P. Can nasal drug delivery bypass the blood-brain barrier? Questioning the direct transport theory. Drugs. R. D. 8 (2007) 133-144
56. Merkus P., Guchelaar H.-J., Bosch A., and Merkus F.W.H.M. Direct access of drugs to the human brain after intranasal drug administration?. Neurology 60 (2003) 1669-1671
57. Miaczynska M., and Stenmark H. Mechanisms and functions of endocytosis. J. Cell. Biol. 180 (2008) 7-11
58. Mistry, A., Glud, S.Z., Kjems, J., Randel, J., Howard, K.A., Stolnik, S., Illum, L., 2009. The effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium. J. Drug Target, doi:10.1080/1061186093055470.
59. Mistry A., 2008. The development and application of biological models for evaluation of direct nose-to-brain drug delivery systems. Thesis, University of Notttingham, UK.
60. Miyamoto M., Natsume H., Satoh I., Ohtake K., Yamaguchi M., Kobayashi D., Sugibayashi K., and Morimoto Y. Effect of poly-l-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (RHG-CSF) in rats. Int. J. Pharm. 226 (2001) 127-138
61. Moran D.T., Rowley J.C., Jafek B.W., and Lovell M.A. The fine-structure of the olfactory mucosa in man. J. Neurocytol. 11 (1982) 721-746
62. Morrison E.E., and Costanzo R.M. Morphology of olfactory epithelium in humans and other vertebrates. Microsc. Res. Tech. 23 (1992) 49-61
63. Mygind N. Nasal Allergy (1979), Blackwell Scientific, Oxford
64. Oberdörster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., and Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16 (2004) 437-445
65. Oberdörster G., Oberdörster E., and Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113 (2005) 823-839
66. Pardridge W.M. Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems. Pharm. Sci. Technol. Today 2 (1999) 49-59
67. Pietrowsky R., Struben C., Molle M., Fehm H.L., and Born J. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose brain pathway for peptide effects in humans. Biol. Psychiatry 39 (1996) 332-340
68. Pietrowsky R., Thiemann A., Kern W., Fehm H.L., and Born J. A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology 21 (1996) 559-572
69. Proetz A. Applied Physiology of the Nose (1953), Annals Publishing Company, St. Louis
70. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377 (2004) 159-169
71. Reynoso-Camacho R., Gonzalez De Mejia E., and Loarca-Pina G. Purification and acute toxicity of a lectin extracted from tepary bean (Phaseolus acutifolius). Food Chem. Toxicol. 41 (2003) 21-27
72. Rhodin J.A.G. Histology a Text and Atlas (1974), Oxford University Press, New York p. 611
73. Rothen-Rutishauser B.M., Schurch S., Haenni B., Kapp N., and Gehr P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Technol. 40 (2006) 4353-4359
74. Sadeghi A.M.M., Dorkoosh F.A., Avadi M.R., Weinhold M., Bayat A., Delie F., Gurny R., Larijani B., Rafiee-Tehrani M., and Junginger H.E. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur. J. Pharm. Biopharm. 70 (2008) 270-278
75. Sakane T., Akizuki M., Taki Y., Yamashita S., Sezaki H., and Nadai T. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs. J. Pharm. Pharmacol. 47 (1995) 379-381
76. Sakane T., Akizuki M., Yamashita S., Nadai T., Hashida M., and Sezaki H. The transport of a drug to the cerebrospinal fluid directly from the nasal cavity the relation to the lipophilicity of the drug. Chem. Pharm. Bull. 39 (1991) 2456-2458
77. Sakane T., Akizuki M., Yamashita S., Sezaki H., and Nadai T. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug. J. Pharm. Pharmacol. 46 (1994) 378-379
78. Semmler M., Seitz J., Erbe F., Mayer P., Heyder J., Oberdorster G., and Kreyling W.G. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal. Toxicol. 16 (2004) 453-459
79. Shipley M.T. Transport of molecules from nose to brain: transneural anterograde and retrograde labelling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res. Bull. 15 (1985) 129-142
80. Smith J., Wood E., and Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm. Res. 21 (2004) 43-49
81. Smith J.M., Dornish M., and Wood E.J. Involvement of protein kinase c in chitosan glutamate-mediated tight junction disruption. Biomaterials 26 (2005) 3269-3276
82. Sorkin A. Cargo recognition during clathrin-mediated endocytosis: a team effort. Curr. Opin. Cell Biol. 16 (2004) 392-399
83. Thorne R.G., Pronk G.J., Padmanabhan V., and Frey W.H. Delivery of insulin-like growth factor-i to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127 (2004) 481-496
84. Tucker D. Nonolfactory Responses from the Nasal Cavity: Jacobson's Organ and the Trigeminal System (1971), Springer, Heidelberg pp. 151-181
85. Van Itallie C.M., and Anderson J.M. Claudins and epithelial paracellular transport. Annu. Rev. Physiol. 68 (2006) 403-429
86. Wan X.M., Chen Y.P., Xu W.R., Yang W.J., and Wen L.P. Identification of nose-to-brain homing peptide through phage display. Peptides 30 (2009) 343-350
87. 3 particles into the brain: micro-distribution, chemical states, and histopathological observation. Biol. Trace Elem. Res. 118 (2007) 233-243
88. Wang J., Liu Y., Jiao F., Lao F., Li W., Gu Y., Li Y., Ge C., Zhou G., Li B., Zhao Y., Chai Z., and Chen C. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicology 254 (2008) 82-90
89. Wang X., He H., Leng W., and Tang X. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method. Int. J. Pharm. 317 (2006) 40-46
90. Wang Y.-Y., Lai S.K., Suk J.S., Pace A., Cone R., and Hanes J. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "Slip". Through the human mucus barrier. Angew. Chem. Int. Ed. Engl. 47 (2008) 9726-9729
91. Westin U., Piras E., Jansson B., Bergstrom U., Dahlin M., Brittebo E., and Bjork E. Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents. Eur. J. Pharm. Sci. 24 (2005) 565-573
92. Xia T., Kovochich M., Liong M., Zink J.I., and Nel A.E. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2 (2008) 85-96
93. Xiang S.D., Scholzen A., Minigo G., David C., Apostolopoulos V., Mottram P.L., and Plebanski M. Pathogen recognition and development of particulate vaccines: does size matter?. Methods 40 (2006) 1-9
94. Zhang Q., Jiang X., Jiang W., Lu W., Su L., and Shi Z. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int. J. Pharm. 275 (2004) 85-96
95. Zhang Q., Liu Y., Yang N., Wan X., and Zuo P. Nasal administration of cholera toxin B subunit-nerve growth factor improves the space learning and memory abilities in beta-amyloid protein (25-35)-induced amnesic mice. Neuroscience 155 (2008) 234-240
96. Zhang Q.Z., Zha L.S., Zhang Y., Jiang W.M., Lu W., Shi Z.Q., Jiang X.G., and Fu S.K. The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats. J. Drug Target. 14 (2006) 281-290